TABLE 1.
Trial | No. of patients | Median wt (kg) (range) | Median ht (cm) (range) | Median age (yr) (range) | No. of male patients |
---|---|---|---|---|---|
I | 77 | 75.3 (61–97.7) | 176.7 (161–190) | 42.5 (19–55) | 71 |
II | 50 | 76.5 (50.9–112.4) | 174.5 (138–200) | 41.5 (19–63) | 42 |
III | 139 | 73.5 (64–140) | 164 (145–186) | 61 (19–90) | 21 |
Summary statistics of demographic data from healthy volunteers receiving oral (trial I) or intravenous (trial II) administrations and from patients receiving intravenous administrations (trial III) of finafloxacin. Medians and ranges (minimum to maximum) are presented.